annual cash & cash equivalents:
$141.19M+$11.04M(+8.48%)Summary
- As of today (September 10, 2025), WGS annual cash & cash equivalents is $141.19 million, with the most recent change of +$11.04 million (+8.48%) on December 31, 2024.
- During the last 3 years, WGS annual cash & cash equivalents has fallen by -$259.38 million (-64.75%).
- WGS annual cash & cash equivalents is now -64.75% below its all-time high of $400.57 million, reached on December 31, 2021.
Performance
WGS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$134.56M-$24.60M(-15.46%)Summary
- As of today (September 10, 2025), WGS quarterly cash & cash equivalents is $134.56 million, with the most recent change of -$24.60 million (-15.46%) on June 30, 2025.
- Over the past year, WGS quarterly cash & cash equivalents has increased by +$27.70 million (+25.92%).
- WGS quarterly cash & cash equivalents is now -70.83% below its all-time high of $461.28 million, reached on September 1, 2021.
Performance
WGS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
WGS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.5% | +25.9% |
| 3 y3 years | -64.8% | -52.7% |
| 5 y5 years | - | +10000.0% |
WGS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.8% | +8.5% | -52.7% | +25.9% |
| 5 y | 5-year | -64.8% | +30.6% | -70.8% | >+9999.0% |
| alltime | all time | -64.8% | +30.6% | -70.8% | >+9999.0% |
WGS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $134.56M(-15.5%) |
| Mar 2025 | - | $159.16M(+12.7%) |
| Dec 2024 | $141.19M(+8.5%) | $141.19M(+21.2%) |
| Sep 2024 | - | $116.46M(+9.0%) |
| Jun 2024 | - | $106.86M(-5.4%) |
| Mar 2024 | - | $112.91M(-13.2%) |
| Dec 2023 | $130.15M(-5.3%) | $130.15M(+13.9%) |
| Sep 2023 | - | $114.30M(-27.0%) |
| Jun 2023 | - | $156.66M(-26.8%) |
| Mar 2023 | - | $214.04M(+55.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $137.40M(-65.7%) | $137.40M(-28.2%) |
| Sep 2022 | - | $191.36M(-32.8%) |
| Jun 2022 | - | $284.65M(-9.6%) |
| Mar 2022 | - | $315.00M(-21.4%) |
| Dec 2021 | $400.57M(+270.4%) | - |
| Dec 2021 | - | $400.57M(-13.2%) |
| Sep 2021 | - | $461.28M(>+9900.0%) |
| Jun 2021 | - | $168.00K(-73.2%) |
| Mar 2021 | - | $627.40K(-99.4%) |
| Dec 2020 | $108.13M | $108.13M(+9385.3%) |
| Sep 2020 | - | $1.14M |
FAQ
- What is GeneDx Holdings Corp. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GeneDx Holdings Corp.?
- What is GeneDx Holdings Corp. annual cash & cash equivalents year-on-year change?
- What is GeneDx Holdings Corp. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for GeneDx Holdings Corp.?
- What is GeneDx Holdings Corp. quarterly cash & cash equivalents year-on-year change?
What is GeneDx Holdings Corp. annual cash & cash equivalents?
The current annual cash & cash equivalents of WGS is $141.19M
What is the all time high annual cash & cash equivalents for GeneDx Holdings Corp.?
GeneDx Holdings Corp. all-time high annual cash & cash equivalents is $400.57M
What is GeneDx Holdings Corp. annual cash & cash equivalents year-on-year change?
Over the past year, WGS annual cash & cash equivalents has changed by +$11.04M (+8.48%)
What is GeneDx Holdings Corp. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of WGS is $134.56M
What is the all time high quarterly cash & cash equivalents for GeneDx Holdings Corp.?
GeneDx Holdings Corp. all-time high quarterly cash & cash equivalents is $461.28M
What is GeneDx Holdings Corp. quarterly cash & cash equivalents year-on-year change?
Over the past year, WGS quarterly cash & cash equivalents has changed by +$27.70M (+25.92%)